Prediction of exposure-response relationships to support first-in-human study design.
about
Antiretroviral pharmacology in mucosal tissuesPrediction of clinical pharmacokinetics of AMG 181, a human anti-α 4 β 7 monoclonal antibody for treating inflammatory bowel diseasesPopulation Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized TrialModeling and predicting clinical efficacy for drugs targeting the tumor milieu.Use of PD biomarkers to drive dose selection and early clinical decision making.Tools for predicting the PK/PD of therapeutic proteins.Developing Exposure/Response Models for Anticancer Drug Treatment: Special ConsiderationsImmunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities.Drug Development of Therapeutic Monoclonal Antibodies.Multiparameter Phase I trials: a tool for model-based development of targeted agent combinations--example of EVESOR trial.On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach.Preclinical pharmacokinetics of the novel PI3K inhibitor GDC-0941 and prediction of its pharmacokinetics and efficacy in human.Translational mixed-effects PKPD modelling of recombinant human growth hormone - from hypophysectomized rat to patients.
P2860
Q27014675-1B0A86AD-EFCB-4053-83CC-6B7E62BA55B0Q35049579-22C4C172-3BF1-4C68-9A4E-4A572DF3FABEQ36031114-338509F1-8C0F-473F-9DD1-C18D6B75A1B1Q38025261-567403AC-9C7D-43F3-8D93-FB208FE44213Q38060202-69641A1A-7C24-4C8D-A55C-53AEF4ED1CC8Q38455786-9E0E60BD-D402-4800-BFEB-446F810ECB84Q38557331-7FD392CE-9EC9-4D9A-B240-CBF0F6003831Q38753955-E13DAA62-9B01-4587-91C4-2C359F249F00Q38876360-6D0CCC79-35AA-49C3-99EE-5C87E9C6792DQ39008372-EC07ACE2-22C8-47BD-BD98-85EA7D2062A2Q39112394-74861287-7768-4654-BAC2-995497DC0AE2Q39491080-05CABB48-4811-4FA1-A7BB-700260B6826BQ39963734-99805A5F-6545-45F7-9A7F-21B515C6BD05
P2860
Prediction of exposure-response relationships to support first-in-human study design.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prediction of exposure-response relationships to support first-in-human study design.
@en
Prediction of exposure-response relationships to support first-in-human study design.
@nl
type
label
Prediction of exposure-response relationships to support first-in-human study design.
@en
Prediction of exposure-response relationships to support first-in-human study design.
@nl
prefLabel
Prediction of exposure-response relationships to support first-in-human study design.
@en
Prediction of exposure-response relationships to support first-in-human study design.
@nl
P2860
P1433
P1476
Prediction of exposure-response relationships to support first-in-human study design.
@en
P2093
John P Gibbs
P2860
P2888
P304
P356
10.1208/S12248-010-9236-7
P407
P577
2010-10-22T00:00:00Z
P5875
P6179
1037671550